The type of anemia resulting from excessive destruction of red blood cells, which may be caused by infection or chemotherapy, is:

Hemolytic anemia is characterized by the premature destruction of red blood cells (RBCs) leading to a decrease in the overall RBC count. This type of anemia can occur due to various factors, including infections, autoimmune disorders, or as a side effect linked to treatments such as chemotherapy. In hemolytic anemia, the body struggles to keep up with the rate of destruction of RBCs, which can manifest in symptoms such as fatigue, pale skin, shortness of breath, and jaundice.

The conditions that lead to hemolytic anemia involve mechanisms that cause the body to destroy red blood cells faster than it can produce them. Understanding this mechanism is crucial for recognizing how the body reacts to certain stressors or treatments, such as infections or the toxic effects of chemotherapy on the bone marrow or blood cells.

In contrast, iron deficiency anemia is primarily a result of insufficient iron intake or absorption, leading to reduced production of hemoglobin. Myelopathic anemia refers to anemia caused by disorders affecting the spinal cord or bone marrow. Pernicious anemia is due to the inability to absorb vitamin B12, which is essential for red blood cell production, rather than destruction of red blood cells. Each of these types has different underlying causes and physiological mechanisms, establishing hem